SCWorx Corp.
SCWorx Corp. scores highest on Torque (62) and lowest on Nitro (5). Its PosiPenta is 35.27 out of 100, weaker than most similar companies.
On the Penta Grid this week, SCWorx Corp. is Grid #661 of 837 in the Healthcare sector in United States, and Grid #3,280 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| SCWorx Corp. | 35.27 | 50 | 22 | 5 | 62 | 38 |
| Lakewood-Amedex Biotherapeutics, Inc. | 28.54 | 48 | 10 | 1 | 38 | 46 |
| Bone Biologics Corporation | 42.16 | 48 | 49 | 14 | 67 | 32 |
| Artelo Biosciences, Inc. | 28.28 | 48 | 40 | 2 | 39 | 12 |
| Curis, Inc. | 42.16 | 96 | 43 | 5 | 41 | 26 |
| Genprex, Inc. | 30.96 | 50 | 39 | 1 | 52 | 13 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.42 |
| P/B ratio | 0.11 |
EEarnings
| Trailing EPS | ₹-313.51 |
| Forward EPS | — |
NNitro
| Price | 130.71 |
| 52-week high | 11200.99 |
| 52-week low | 101.34 |
| Fall from 52-week high | 98.8% |
TTorque
| Return on equity (ROE) | -38.06% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 1.29 |
| Market cap | ₹7 Cr |
| Insider holding | 10.28% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is SCWorx Corp.'s PosiPenta score?
SCWorx Corp.'s PosiPenta is 35.27 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does SCWorx Corp. stand on the Penta Grid?
On the Penta Grid this week, SCWorx Corp. is Grid #661 of 837 in the Healthcare sector in United States, and Grid #3,280 of 4,000 in United States.
Which PosiPenta pillar is strongest for SCWorx Corp.?
Torque (durability), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for SCWorx Corp.?
Nitro (momentum), with a score of 5 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.